Continuous penetration testing tools close the gap in coverage left by annual pentests. This guide breaks down the best options, what each tool actually does, and how to choose.

As general-purpose and domain-specific AI models rapidly infiltrate drug discovery, one critical question looms over the pharmaceutical sector: Can these models actually discover drugs, or are they ...

A key theme emerging from FDA complete response letters since 2018 is that data system validation is lacking in the ...

Spread the loveAh, the PDF. It’s the digital equivalent of that ubiquitous manila folder we used to shuffle around the office. We all encounter them, often daily, whether it’s an invoice, a job ...

Background/Aims Retinopathy of prematurity (ROP) zone classification guides disease severity assessment and Early Treatment ...

We recognise there is growing interest in NHS England’s ongoing patient list validation programme and the use of FP69 processes where there is evidence that a patient may no longer be resident in ...

Arabian Post Staff -DubaiAzentio Software has launched a UAE e-invoicing solution inside its enterprise resource planning platform, positioning the product around the Federal Tax Authority mandate ...

Computer system validation (CSV) has governed good-practice (GxP) software compliance for over three decades, and for deterministic systems, it works well. But software driven by artificial ...

Welcome to the official research repository for SSOT-Centric Software Engineering (SCSE). This repository serves as the authoritative central hub for the conception, design, implementation, validation ...

Background Accurate device sizing is crucial for successful flow diverter (FD) therapy in intracranial aneurysms. This study assesses the accuracy and clinical utility of the Ankyras virtual ...

Months after announcing a new program to validate self-reported nursing home quality data, the Centers for Medicare & Medicaid Services has begun notifying providers of their selection. Multiple ...

Chemotherapy plus anti-PD-1 or anti-PD-L1 in advanced PD-L1–negative squamous cell lung carcinoma: A systematic review and meta-analysis. First-line camrelizumab plus chemotherapy in patients with ...